These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25940221)

  • 1. Topical delivery of dexamethasone acetate from hydrogel containing nanostructured liquid carriers and the drug.
    Tung NT; Huyen VT; Chi SC
    Arch Pharm Res; 2015 Nov; 38(11):1999-2007. PubMed ID: 25940221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole.
    Lin WJ; Duh YS
    Eur J Pharm Biopharm; 2016 Nov; 108():297-303. PubMed ID: 27449633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
    Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y
    Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
    Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
    Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
    Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
    Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
    Wang Y; Wang S; Shi P
    Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
    Rajinikanth PS; Chellian J
    Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
    Shinde UA; Parmar SJ; Easwaran S
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum.
    Guo T; Zhang Y; Zhao J; Zhu C; Feng N
    J Nanobiotechnology; 2015 Jul; 13():47. PubMed ID: 26156035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies.
    Elmowafy M; Shalaby K; Ali HM; Alruwaili NK; Salama A; Ibrahim MF; Akl MA; Ahmed TA
    Int J Pharm; 2019 Dec; 572():118781. PubMed ID: 31715347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
    Fan X; Chen J; Shen Q
    Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
    Nnamani PO; Hansen S; Windbergs M; Lehr CM
    Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.